Erratum: Inflammation and preneoplastic lesions in benign prostate as risk factors for prostate cancer (Modern Pathology (2012) 25 (1023-1032) DOI: 10.1038/modpathol.2012.51);Inflammation and preneoplastic lesions in benign prostate as risk factors for prostate cancer

Modern Pathology

Volumn 25, Issue 7, 2012, Pages 1023-1032

  Kryvenko, Oleksandr N ^a   Jankowski, Michelle ^a   Chitale, Dhananjay A ^a   Tang, Deliang ^b   Rundle, Andrew ^b   Trudeau, Sheri ^a   Rybicki, Benjamin A ^a  

^a HENRY FORD HOSPITAL   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

atrophy; cancer risk; prostate; stromal inflammation

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AGED; ARTICLE; ATROPHY; BENIGN TUMOR; CANCER GRADING; CANCER RISK; CASE CONTROL STUDY; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; HUMAN; HUMAN TISSUE; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE TUMOR; PROSTATIC INTRAEPITHELIAL NEOPLASIA; RACE; RISK; SOFT TISSUE INFLAMMATION;

EID: 84863458727     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2012.185     Document Type: Erratum

References (40)

1. De Marzo AM, Platz EA, Epstein JI, et al. A working group classification of focal prostate atrophy lesions. Am J Surg Pathol 2006;30:1281-1291. (Pubitemid 44454708)
2. Billis A, Magna LA. Inflammatory atrophy of the prostate. Prevalence and significance. Arch Pathol Lab Med 2003;127:840-844. (Pubitemid 36792311)
3. Nickel JC, True LD, Krieger JN, et al. Consensus development of a histopathological classification system for chronic prostatic inflammation. BJU Int 2001;87:797-805. (Pubitemid 34204319)
4. Postma R, Schroder FH, van der Kwast TH. Atrophy in prostate needle biopsy cores and its relationship to prostate cancer incidence in screened men. Urology 2005;65:745-749. (Pubitemid 40523011)
5. McNeal JE, Bostwick DG. Intraductal dysplasia: a premalignant lesion of the prostate. Hum Pathol 1986; 17:64-71. (Pubitemid 16163546)
6. Bostwick DG, Qian J. High-grade prostatic intraepithelial neoplasia. Mod Pathol 2004;17:360-379. (Pubitemid 41646613)
7. Epstein JI, Herawi M. Prostate needle biopsies containing prostatic intraepithelial neoplasia or atypical foci suspicious for carcinoma: implications for patient care. J Urol 2006;175:820-834. (Pubitemid 43199991)
8. Descazeaud A, Rubin MA, Allory Y, et al. What information are urologists extracting from prostate needle biopsy reports and what do they need for clinical management of prostate cancer? Eur Urol 2005;48:911-915. (Pubitemid 41641634)
9. De Matteis M, Poggi C, De Martino A, et al. Repeat biopsy in patients with initial diagnosis of PIN. Radiol Med 2005;110:190-198. (Pubitemid 41666008)
10. Borboroglu PG, Sur RL, Roberts JL, et al. Repeat biopsy strategy in patients with atypical small acinar proliferation or high grade prostatic intraepithelial neoplasia on initial prostate needle biopsy. J Urol 2001; 166:866-870. (Pubitemid 32750968)
11. Netto GJ, Epstein JI. Widespread high-grade prostatic intraepithelial neoplasia on prostatic needle biopsy: a significant likelihood of subsequently diagnosed adenocarcinoma. Am J Surg Pathol 2006;30:1184-1188. (Pubitemid 44299352)
12. Putzi MJ, De Marzo AM. Morphologic transitions between proliferative inflammatory atrophy and highgrade prostatic intraepithelial neoplasia. Urology 2000;56:828-832.
13. WangW, Bergh A, Damber JE. Morphological transition of proliferative inflammatory atrophy to high-grade intraepithelial neoplasia and cancer in human prostate. Prostate 2009;69:1378-1386.
14. McNeal JE. Normal histology of the prostate. Am J Surg Pathol 1988;12:619-633.
15. De Marzo AM, Marchi VL, Epstein JI, et al. Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis. Am J Pathol 1999; 155:1985-1992.
16. De Marzo AM, Nakai Y, Nelson WG. Inflammation, atrophy, and prostate carcinogenesis. Urol Oncol 2007;25:398-400. (Pubitemid 47362760)
17. Liavag I. Mitotic activity of prostatic epithelium. A study by means of Colcemid. Acta Pathol Microbiol Scand 1968;73:19-28.
18. Ruska KM, Sauvageot J, Epstein JI. Histology and cellular kinetics of prostatic atrophy. Am J Surg Pathol 1998;22:1073-1077. (Pubitemid 28411064)
19. Feneley MR, Young MP, Chinyama C, et al. Ki-67 expression in early prostate cancer and associated pathological lesions. J Clin Pathol 1996;49:741-748. (Pubitemid 26297700)
20. Gardner Jr WA, Culberson DE. Atrophy and proliferation in the young adult prostate. J Urol 1987;137: 53-56. (Pubitemid 17214223)
21. Tomas D, Kruslin B, Rogatsch H, et al. Different types of atrophy in the prostate with and without adenocarcinoma. Eur Urol 2007;51:98-103; discussion 103-104.
22. De Marzo AM, Platz EA, Sutcliffe S, et al. Inflammation in prostate carcinogenesis. Nat Rev Cancer 2007;7:256-269. (Pubitemid 46486616)
23. MacLennan GT, Eisenberg R, Fleshman RL, et al. The influence of chronic inflammation in prostatic carcinogenesis: a 5-year followup study. J Urol 2006;176: 1012-1016. (Pubitemid 44142579)
24. Terakawa T, Miyake H, Kanomata N, et al. Inverse association between histologic inflammation in needle biopsy specimens and prostate cancer in men with serum PSA of 10-50 ng/mL. Urology 2008;72: 1194-1197.
25. International consultation on prostatic intraepithelial neoplasia and pathologic staging of prostatic carcinoma. Rochester, Minnesota, November 3-4, 1995. Cancer 1996;78:320-381.
26. Schatteman PH, Hoekx L, Wyndaele JJ, et al. Inflammation in prostate biopsies of men without prostatic malignancy or clinical prostatitis: correlation with total serum PSA and PSA density. Eur Urol 2000; 37:404-412. (Pubitemid 30157801)
27. Stimac G, Reljic A, Spajic B, et al. Aggressiveness of inflammation in histological prostatitis-correlation with total and free prostate specific antigen levels in men with biochemical criteria for prostate biopsy. Scott Med J 2009;54:8-12.
28. Bostwick DG, Amin MB, Dundore P, et al. Architectural patterns of high-grade prostatic intraepithelial neoplasia. Hum Pathol 1993;24:298-310. (Pubitemid 23086366)
29. Epstein JI, Netto GJ. Prostatic and intraepithelial neoplasia and its mimickers. In: Epstein JI (ed). Biopsy Interpretation of the Prostate 4th edn. LWW: Philadelphia, 2008, pp 35-67.
30. Davidson D, Bostwick DG, Qian J, et al. Prostatic intraepithelial neoplasia is a risk factor for adenocarcinoma: predictive accuracy in needle biopsies. J Urol 1995;154:1295-1299.
31. Lee MC, Moussa AS, Yu C, et al. Multifocal high grade prostatic intraepithelial neoplasia is a risk factor for subsequent prostate cancer. J Urol 2010;184:1958-1962.
32. Merrimen JL, Jones G, Walker D, et al. Multifocal high grade prostatic intraepithelial neoplasia is a significant risk factor for prostatic adenocarcinoma. J Urol 2009;182:485-490; discussion 490.
33. Merrimen JL, Jones G, Srigley JR. Is high grade prostatic intraepithelial neoplasia still a risk factor for adenocarcinoma in the era of extended biopsy sampling? Pathology 2010;42:325-329.
34. Palapattu GS, Sutcliffe S, Bastian PJ, et al. Prostate carcinogenesis and inflammation: emerging insights. Carcinogenesis 2005;26:1170-1181. (Pubitemid 41417894)
35. Asimakopoulos AD, Miano R, Mauriello A, et al. Significance of focal proliferative atrophy lesions in prostate biopsy cores that test negative for prostate carcinoma. Urol Oncol 2011;29:690-697.
36. Stamatiou K, Alevizos A, Agapitos E, et al. Incidence of impalpable carcinoma of the prostate and of nonmalignant and precarcinomatous lesions in Greek male population: an autopsy study. Prostate 2006;66:1319-1328. (Pubitemid 44389158)
37. Wolters T, Roobol MJ, Schroder FH, et al. Can nonmalignant biopsy features identify men at increased risk of biopsy-detectable prostate cancer at re-screening after 4 years? BJU Int 2008;101:283-288.
38. Sakr WA, Grignon DJ, Crissman JD, et al. High grade prostatic intraepithelial neoplasia (HGPIN) and prostatic adenocarcinoma between the ages of 20-69: an autopsy study of 249 cases. In Vivo 1994;8:439-443.
39. Nonn L, Ananthanarayanan V, Gann PH. Evidence for field cancerization of the prostate. Prostate 2009; 69:1470-1479.
40. NIH. Surveillance Epidemiology and End Results. Stat Fact Sheets: Prostate.http://www.seer.cancer.gov/statfacts/html/prost.html 2011.